A UK biotechnology company has been developing and testing vaccines for common allergies. The vaccines use SPIREs (synthetic peptides that regulate immune system cells) to help people fend off their allergies to cats, grasses and dust mites. The Science Show's Chris Creese spoke with Professor Mark Larché who is leading these clinical trials.

Want to learn more?

Research: McMaster T-cell Epitope Centre

Biotech: Circassia ToleroMune technology